RIZPOZI Trademark

Trademark Overview

On Tuesday, February 28, 2023, a trademark application was filed for RIZPOZI with the United States Patent and Trademark Office. The USPTO has given the RIZPOZI trademark a serial number of 97814820. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, February 14, 2025. This trademark is owned by Immunovant Sciences GmbH. The RIZPOZI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of autoimmune diseases and disorders, neuromuscular diseases and disorders, neurological diseases and disorders, and ocular diseases and disorders
rizpozi

General Information

Serial Number97814820
Word MarkRIZPOZI
Filing DateTuesday, February 28, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, February 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of autoimmune diseases and disorders, neuromuscular diseases and disorders, neurological diseases and disorders, and ocular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunovant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4051
CH
Party NameImmunovant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events

Event DateEvent Description
Friday, March 3, 2023NEW APPLICATION ENTERED
Monday, March 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 8, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 19, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, November 29, 2023ASSIGNED TO EXAMINER
Tuesday, December 5, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, December 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 8, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, December 14, 2023ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 5, 2024SOU EXTENSION 1 FILED
Thursday, September 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 5, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, September 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 14, 2025SOU TEAS EXTENSION RECEIVED
Friday, February 14, 2025SOU EXTENSION 2 FILED
Friday, February 14, 2025SOU EXTENSION 2 GRANTED
Friday, February 14, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 10, 2025SOU EXTENSION 1 GRANTED

Related Keywords

rizpozi diseases disorders neuromuscular neurological ocular autoimmune preparations human prevention treatment